Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination

Yuning Liao, Xiaohong Xia, Ningning Liu, Jianyu Cai, Zhiqiang Guo, Yanling Li, Lili Jiang, Q. Ping Dou, Daolin Tang, Hongbiao Huang, Jinbao Liu

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

It has been well known that androgen receptor (AR) is critical to prostate cancer development and progression. It has also been documented that AR is expressed in more than 60% of breast tumors, which promotes the growth of estrogen receptor-negative (ER - )/AR-positive (AR + ) breast cancer cells. Thus, AR might be a potential therapeutic target for AR-positive/ER-negative breast cancer patients. Previously we reported that in prostate cancer cells proteasome-associated deubiquitinase ubiquitin-specific protease 14 (USP14) stabilized AR protein level by removing its ubiquitin chain. In the current study, we studied the USP14-AR protein interaction and cell proliferation status after USP14 reduction or inhibition in breast cancer cells, and our results support the conclusion that targeting USP14 is a novel strategy for treating AR-responsive breast cancer. We found that inhibition of USP14 accelerated the K48-ubiquitination and proteasome-mediated degradation of AR protein. Additionally, both genetic and pharmacological inhibition of USP14 significantly suppressed cell proliferation in AR-responsive breast cancer cells by blocking G 0 /G 1 to S phase transition and inducing apoptosis. Moreover, AR overexpression inhibited USP14 inhibition-induced events, suggesting that AR deubiquitination by USP14 is critical for breast cancer growth and USP14 inhibition is a possible strategy to treat AR-positive breast cancer.

Original languageEnglish (US)
Pages (from-to)1896-1910
Number of pages15
JournalOncogene
Volume37
Issue number14
DOIs
StatePublished - Apr 1 2018
Externally publishedYes

Fingerprint

Ubiquitin-Specific Proteases
Androgen Receptors
Apoptosis
Breast Neoplasms
Growth
Proteasome Endopeptidase Complex
human AR protein
Prostatic Neoplasms
Cell Proliferation
Gastrin-Secreting Cells
Proteins
Ubiquitination
Phase Transition

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination. / Liao, Yuning; Xia, Xiaohong; Liu, Ningning; Cai, Jianyu; Guo, Zhiqiang; Li, Yanling; Jiang, Lili; Dou, Q. Ping; Tang, Daolin; Huang, Hongbiao; Liu, Jinbao.

In: Oncogene, Vol. 37, No. 14, 01.04.2018, p. 1896-1910.

Research output: Contribution to journalArticle

Liao, Yuning ; Xia, Xiaohong ; Liu, Ningning ; Cai, Jianyu ; Guo, Zhiqiang ; Li, Yanling ; Jiang, Lili ; Dou, Q. Ping ; Tang, Daolin ; Huang, Hongbiao ; Liu, Jinbao. / Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination. In: Oncogene. 2018 ; Vol. 37, No. 14. pp. 1896-1910.
@article{263bdb3b6de84b4488774f44966d03ad,
title = "Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination",
abstract = "It has been well known that androgen receptor (AR) is critical to prostate cancer development and progression. It has also been documented that AR is expressed in more than 60{\%} of breast tumors, which promotes the growth of estrogen receptor-negative (ER - )/AR-positive (AR + ) breast cancer cells. Thus, AR might be a potential therapeutic target for AR-positive/ER-negative breast cancer patients. Previously we reported that in prostate cancer cells proteasome-associated deubiquitinase ubiquitin-specific protease 14 (USP14) stabilized AR protein level by removing its ubiquitin chain. In the current study, we studied the USP14-AR protein interaction and cell proliferation status after USP14 reduction or inhibition in breast cancer cells, and our results support the conclusion that targeting USP14 is a novel strategy for treating AR-responsive breast cancer. We found that inhibition of USP14 accelerated the K48-ubiquitination and proteasome-mediated degradation of AR protein. Additionally, both genetic and pharmacological inhibition of USP14 significantly suppressed cell proliferation in AR-responsive breast cancer cells by blocking G 0 /G 1 to S phase transition and inducing apoptosis. Moreover, AR overexpression inhibited USP14 inhibition-induced events, suggesting that AR deubiquitination by USP14 is critical for breast cancer growth and USP14 inhibition is a possible strategy to treat AR-positive breast cancer.",
author = "Yuning Liao and Xiaohong Xia and Ningning Liu and Jianyu Cai and Zhiqiang Guo and Yanling Li and Lili Jiang and Dou, {Q. Ping} and Daolin Tang and Hongbiao Huang and Jinbao Liu",
year = "2018",
month = "4",
day = "1",
doi = "10.1038/s41388-017-0069-z",
language = "English (US)",
volume = "37",
pages = "1896--1910",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "14",

}

TY - JOUR

T1 - Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination

AU - Liao, Yuning

AU - Xia, Xiaohong

AU - Liu, Ningning

AU - Cai, Jianyu

AU - Guo, Zhiqiang

AU - Li, Yanling

AU - Jiang, Lili

AU - Dou, Q. Ping

AU - Tang, Daolin

AU - Huang, Hongbiao

AU - Liu, Jinbao

PY - 2018/4/1

Y1 - 2018/4/1

N2 - It has been well known that androgen receptor (AR) is critical to prostate cancer development and progression. It has also been documented that AR is expressed in more than 60% of breast tumors, which promotes the growth of estrogen receptor-negative (ER - )/AR-positive (AR + ) breast cancer cells. Thus, AR might be a potential therapeutic target for AR-positive/ER-negative breast cancer patients. Previously we reported that in prostate cancer cells proteasome-associated deubiquitinase ubiquitin-specific protease 14 (USP14) stabilized AR protein level by removing its ubiquitin chain. In the current study, we studied the USP14-AR protein interaction and cell proliferation status after USP14 reduction or inhibition in breast cancer cells, and our results support the conclusion that targeting USP14 is a novel strategy for treating AR-responsive breast cancer. We found that inhibition of USP14 accelerated the K48-ubiquitination and proteasome-mediated degradation of AR protein. Additionally, both genetic and pharmacological inhibition of USP14 significantly suppressed cell proliferation in AR-responsive breast cancer cells by blocking G 0 /G 1 to S phase transition and inducing apoptosis. Moreover, AR overexpression inhibited USP14 inhibition-induced events, suggesting that AR deubiquitination by USP14 is critical for breast cancer growth and USP14 inhibition is a possible strategy to treat AR-positive breast cancer.

AB - It has been well known that androgen receptor (AR) is critical to prostate cancer development and progression. It has also been documented that AR is expressed in more than 60% of breast tumors, which promotes the growth of estrogen receptor-negative (ER - )/AR-positive (AR + ) breast cancer cells. Thus, AR might be a potential therapeutic target for AR-positive/ER-negative breast cancer patients. Previously we reported that in prostate cancer cells proteasome-associated deubiquitinase ubiquitin-specific protease 14 (USP14) stabilized AR protein level by removing its ubiquitin chain. In the current study, we studied the USP14-AR protein interaction and cell proliferation status after USP14 reduction or inhibition in breast cancer cells, and our results support the conclusion that targeting USP14 is a novel strategy for treating AR-responsive breast cancer. We found that inhibition of USP14 accelerated the K48-ubiquitination and proteasome-mediated degradation of AR protein. Additionally, both genetic and pharmacological inhibition of USP14 significantly suppressed cell proliferation in AR-responsive breast cancer cells by blocking G 0 /G 1 to S phase transition and inducing apoptosis. Moreover, AR overexpression inhibited USP14 inhibition-induced events, suggesting that AR deubiquitination by USP14 is critical for breast cancer growth and USP14 inhibition is a possible strategy to treat AR-positive breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=85040724283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040724283&partnerID=8YFLogxK

U2 - 10.1038/s41388-017-0069-z

DO - 10.1038/s41388-017-0069-z

M3 - Article

C2 - 29353883

AN - SCOPUS:85040724283

VL - 37

SP - 1896

EP - 1910

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 14

ER -